FDA Approves Veklury® for the Treatment of Non-Hospitalized Patients at High Risk for COVID-19 Disease Progression Pharmaceutical Investing
U.S. FDA Approves Second Indication for SKYRIZI® to Treat Adults with Active Psoriatic Arthritis Pharmaceutical Investing
Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency Pharmaceutical Investing
BetterLife Receives FDA Response On Its Pre-IND Application For Major Depressive Disorder Treatment With BETR-001 Pharmaceutical Investing
Dr. Yehia Hashad Will Join Bausch + Lomb Corporation as Executive Vice President of Research & Development and Chief Medical Officer Pharmaceutical Investing
Results From Pivotal Phase 3 KEYNOTE-775/Study 309 Trial of KEYTRUDA® Plus LENVIMA® in Advanced Endometrial Carcinoma Published in the New England Journal of Medicine Pharmaceutical Investing
Kelburn Mental Health & Addiction Treatment Centre Announces New Ownership, New Leadership and New Modalities Pharmaceutical Investing
Numinus Announces Key Milestones in MAPS-Sponsored MDMA-Assisted Therapy for PTSD Clinical Trial Pharmaceutical Investing
